150 related articles for article (PubMed ID: 30726474)
1. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD4
Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
[TBL] [Abstract][Full Text] [Related]
3. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
Sarac E; Demirkesen C
An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
[No Abstract] [Full Text] [Related]
6. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Small/Medium CD4+ Pleomorphic T-Cell Lymphoma-Like Nodule in a Patient With Erythema Chronicum Migrans.
Celebi Cherukuri N; Roth CG; Aggarwal N; Ho J; Gehris R; Akilov OE
Am J Dermatopathol; 2016 Jun; 38(6):448-52. PubMed ID: 27097344
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous CD4
Maurelli M; Colato C; Gisondi P; Girolomoni G
J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
Grogg KL; Jung S; Erickson LA; McClure RF; Dogan A
Mod Pathol; 2008 Jun; 21(6):708-15. PubMed ID: 18311111
[TBL] [Abstract][Full Text] [Related]
13. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
[TBL] [Abstract][Full Text] [Related]
15. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
Gru AA; Wick MR; Eid M
Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M
Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331
[TBL] [Abstract][Full Text] [Related]
20. Dermoscopy of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Rodríguez-Lomba E; Lobato-Berezo A; Pulido-Pérez A; Parra-Blanco V; Avilés-Izquierdo JA
Int J Dermatol; 2020 Jun; 59(6):755-757. PubMed ID: 32010958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
